Radiology services company Radiologix will be on its own for a while. Its planned merger with Saunders Karp & Megrue (SKM), a bank specializing in private investments, has been canceled by SKM. Radiologix, which will remain a publicly traded company,
Radiology services company Radiologix will be on its own for a while. Its planned merger with Saunders Karp & Megrue (SKM), a bank specializing in private investments, has been canceled by SKM. Radiologix, which will remain a publicly traded company, derives most of its revenue from diagnostic imaging procedures conducted at 124 physician-owned or -operated imaging centers located in 18 states and the District of Columbia.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.